Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical γ-aminobutyric acid neurons in subjects with schizophrenia

Archives of General Psychiatry

Volumn 57, Issue 3, 2000, Pages 237-245

  Volk, David W ^a   Austin, Mark C ^a   Pierri, Joseph N ^a   Sampson, Allan R ^b   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; GLUTAMATE DECARBOXYLASE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MESSENGER RNA; PERPHENAZINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONKEY; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RNA ANALYSIS; SCHIZOPHRENIA;

EID: 0034011252     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.3.237     Document Type: Article

References (59)

1. Simpson MDC, Slater P, Deakin JFW, Royston MC, Skan WJ. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett. 1989;107:211-215.
2. Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett. 1991;121:77-80.
3. Simpson MDC, Slater P, Royston MC, Deakin JFW. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia. Psychiatry Res. 1992;42:273-282.
4. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Teuting P, Sharma RP, Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A. 1998;95:15718-15723.
5. 3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci. 1987;40:239-266.
6. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 1992;12:924-929.
7. A receptors and decreased serotonin-2a receptors in schizophrenia [abstract]. Soc Neurosci Abstracts 1998;24:1274.
8. A receptor subunit expression in schizophrenic prefrontal cortex [abstract]. Soc Neurosci Abstracts. 1998;24:1274.
9. Huntsman MM, Tran BV, Potkin SG, Bunney WE, Jones EG. Altered ratios of alternatively spliced long and short γ 2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A. 1998;95:15066-15071.
10. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
11. Lewis DA. Neural circuitry of the prefrontal cortex in schizophrenia. Arch Gen Psychiatry. 1995;52:269-273.
12. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
13. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch Sen Psychiatry. 1997;54:943-952.
14. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Bell G. The consortium to establish a registry for Alzheimer's disease (CERAD), part II: standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
15. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 1995;59:81-96.
16. Bu DF, Erlander MG, Hitz BC, Tillikaratne N, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A. 1992;89:2115-2119.
17. Gao B, Moore RY. The sexually dimorphic nucleus of the hypothalamus contains GABA neurons in rat and man. Brain Res. 1996;472:163-171.
18. Austin MC, Bradley CC, Mann JJ, Blakely RD. Expression of serotonin transporter messenger RNA in the human brain. J Neurochem. 1994;62:2362-2367.
19. Austin MC, O'Donnell SM. Regional distribution and cellular expression of tryptophan hydroxylase messenger RNA in postmortem human brainstem and pineal gland. J Neurochem. 1999;72:2065-2073.
20. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Lewis DA. Lamina-specific alteration in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry. 1999;156:1580-1589.
21. Pierri JN, Chaudry AS, Woo T-U, Lewis DA. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry. 1999;156:1709-1719.
22. Janicak PG, Davis JM, Preskorn SH, Ayd FJ. Principles and Practice of Psychopharmacotherapy. Baltimore, Md: Williams & Wilkins; 1993.
23. Gerten CR, McGinty JF, Young WS. Dopamine differentially regulates dynorphin, substance P, and enkaphalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci. 1991;11:1016-1031.
24. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Models. Chicago, III: Irwin; 1996.
25. Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett. 1995;200:151-154.
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
27. Hendry SHC, Schwark HD, Jones EG, Yan J. Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J Neurosci. 1987;7:1503-1519.
28. Benes FM, McSparren J, Bird ED, SanGiovanni JP. Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48:996-1001.
29. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52:805-818.
30. Woo T-U, Miller JL, Lewis DA. Parvalbumin-containing cortical neurons in schizophrenia. Am J Psychiatry. 1997;154:1013-1015.
31. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol. 1998;392:402-412.
32. Thune JJ, Hofsten DE, Uylings HBH, Pakkenberg B. Total neuron numbers in the prefrontal cortex in schizophrenia [abstract]. Soc Neurosci Abstracts. 1998; 24:985.
33. Glantz LA, Austin MC, Lewis DA. Cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia [abstract]. Soc Neurosci Abstracts. 1998;24:987.
34. Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A. 1998;95:5341-5346.
35. Lewis DA, Lund JS. Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor and parvalbumin immunoreactive populations. J Comp Neurol. 1990;293:599-615.
36. Delfs JM, Ellison GD, Mercugliano M, Chesselet M-F. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Exp Neurol. 1995;133:175-188.
37. Chen JF, Weiss B. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum. Neurosci Lett. 1993;150:215-218.
38. Jolkkonen J, Jenner P, Marsden CD. GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Neurosci Lett. 1994;180:273-276.
39. Delfs JM, Anegawa NJ, Chesselet M-F. Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine, and combined haloperidol-scopolamine treatments. Neuroscience. 1995;66:67-80.
40. Camps M, Cortés R, Gueye B, Probst A, Palacios JM. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience. 1989;28: 275-290.
41. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1-and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology. 1994;11:245-256.
42. Guillery RW, Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol. 1997;386:2-7.
43. Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry. 1988;145:154-163.
44. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 1992;49:921-926.
45. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 1992; 49:195-205.
46. Zipursky RB, Lambe EK, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry. 1998;55:540-546.
47. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze VII, O'Leary DS, Ehrhardt JC, Yuh WT. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 1994;272:1763-1769.
48. Isaacson JS, Soils JM, Nicoll RA. Local and diffuse synaptic action of GABA in the hippocampus. Neuron. 1993;10:165-175.
49. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606-612.
50. Jones SR, Gainetdinov RR, Jaber M, Giro B, Wightman RM. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci U S A. 1998;95:4029-4034.
51. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 1990;47:1023-1028.
52. Manaye KF, Liang C-L, Hicks PB, German D, Young KA. Nerve cell numbers in thalamic anterior and mediodorsal nuclei are selectively reduced in schizophrenia [abstract]. Soc Neurosci Abstracts. 1998;24:1236.
53. Jones L, Mall N, Byne W. Localization of schizophrenia-associated thalamic volume loss [abstract]. Soc Neurosci Abstracts. 1998;24:985.
54. Popken GJ, Bunney Jr WE, Potkin SG, Jones EG. Neuron number and GABAergic and glutamatergic mRNA expression in subdivisions of the thalamic mediodorsal nucleus of schizophrenics [abstract]. Soc Neurosci Abstracts. 1998;24:991.
55. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65-73.
56. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TRE, Hirsch SR. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446-453.
57. Cruz DA, Melchitzky DS, Lewis DA. Parvalbumin-immunoreactive varicosities are selectively decreased in the thalamic recipient zone of the prefrontal cortex in schizophrenia [abstract]. Soc Neurosci Abstracts. 1999;25:817.
58. Hendry SHC, Jones EG. Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys. Neuron. 1988;1:701-712.
59. Benson DL, Huntsman MM, Jones EG. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb Cortex. 1994; 4:40-51.